Frontiers in immunology
Cure8 research brief
Why This Matters
The review connects molecular cell-cycle changes to the progression from chronic IBD to colorectal cancer, pointing to pathways and cell-cycle regulators that could become prevention or treatment targets for colitis-associated cancer.
Who Should Pay Attention
Researchers, translational scientists, and clinicians focused on IBD-associated colorectal cancer risk and prevention
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a review article (abstract-level content supplied) that synthesizes findings from single-cell omics and molecular studies showing differences in cell-cycle states between IBD epithelial cells and malignant colorectal cells (G1 arrest/excess proliferation in IBD vs G2/M predominance in cancer).
It discusses core pathways (Rb–E2F, NF-κB, JAK–STAT, Hippo–YAP), cyclins/CDKs and CDK inhibitors, and the role of oxidative stress and DNA damage in disrupting checkpoints during the inflammation-to-cancer transition.
The review proposes potential new targets and combination strategies focused on cell-cycle regulation to address colitis-associated colorectal carcinogenesis.
Keep In Mind
This is a review (abstract-level content provided). It synthesizes existing single-cell and molecular studies and proposes targets/strategies but does not present new clinical trial data.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFrontiers in immunology
AuthorsFu Y, Wang Y, Wu S +7 more
Study typeReview, journal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJul 6, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study
The study will prospectively evaluate how often dysplasia occurs, how lesions look and behave after endoscopic resection, and what factors predict local or distant recurrence—information that could change surveillance...
Nanoparticle technologies in the diagnosis and therapy of gastrointestinal diseases: Progress, challenges, and future directions.
Nanoparticle technologies could eventually enable more targeted drug delivery and improved imaging for IBD and related GI diseases, which may lead to better diagnosis and less systemic side effects. However, translation...
RNA-binding protein RBM47 in health and disease: molecular mechanisms, preclinical evidence, and translational challenges.
Researchers are investigating RBM47 because it influences RNA processing and immune pathways that could modify inflammation and disease processes relevant to IBD. If borne out, RBM47 could become a biomarker or...